HomeVERV • NASDAQ
add
Verve Therapeutics Inc
Previous close
$4.32
Day range
$4.25 - $4.71
Year range
$2.86 - $9.31
Market cap
412.73M USD
Avg Volume
4.78M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 32.98M | 479.03% |
Operating expense | 15.15M | 7.00% |
Net income | -31.03M | 36.32% |
Net profit margin | -94.11 | 89.00% |
Earnings per share | -0.35 | 40.68% |
EBITDA | -34.92M | 36.75% |
Effective tax rate | -0.26% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 497.08M | -18.02% |
Total assets | 614.16M | -16.14% |
Total liabilities | 140.65M | -5.79% |
Total equity | 473.51M | — |
Shares outstanding | 89.14M | — |
Price to book | 0.81 | — |
Return on assets | -14.52% | — |
Return on capital | -16.57% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -31.03M | 36.32% |
Cash from operations | -27.84M | 35.37% |
Cash from investing | -48.17M | -15.70% |
Cash from financing | 7.00K | -99.97% |
Net change in cash | -76.01M | -22.63% |
Free cash flow | 1.66M | 105.60% |
About
Founded
2018
Headquarters
Website
Employees
274
